疫苗学《Vaccines》——6th Edition by (美)普洛特金

rojjer

Vaccines, 6th Edition

# O* S5 w- J, QApply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.
  P! g' F$ [5 E, l* w: \( x7 Z. ~
2 o( n5 z% }& j) s" F9 rhttp://yun.baidu.com/share/link?shareid=2079860221&uk=3810996606

SECTION 1: General aspects of vaccination
1 A short history of vaccination 1
2 Vaccine immunology 14
3 The vaccine industry 33
: `' f! b# \4 ]5 C4 Vaccine manufacturing 44
5 Evolution of adjuvants across the centuries 58
6 Vaccine additives and manufacturing residuals in the United States:
licensed vaccines 71
7 Passive immunization 80
8 General immunization practices 88
) }& C. ^# ?5 \) _SECTION 2: Licensed vaccines
5 O3 x: m! b- @9 Adenovirus vaccines 113
$ }' v# V. n" y0 f. n6 R10 Anthrax vaccines 127
5 d2 G# x( H% T; ^- Z11 Cholera vaccines 141
7 s- H  o  p5 O/ @  s1 A; y12 Diphtheria toxoid 153
13 Haemophilus influenzae vaccines 167
( L8 F: L8 T( \: b14 Hepatitis A vaccines 183
15 Hepatitis B vaccines 205
7 b" A( H: R" {% i& d% z16 Human papillomavirus vaccines 235
17 Inactivated influenza vaccines 257
18 Influenza vaccine-live 294
+ }" t2 L1 g2 {+ x5 d4 h5 n' X2 N19 Japanese encephalitis vaccines 312
  E# Q5 O- a# y8 @20 Measles vaccines 352
21 Meningococcal vaccines 388
22 Mumps vaccine 419
+ w- ^9 S0 j3 Y& F) Q23 Pertussis vaccines . 447
: S" g$ r/ H5 X; f7 K+ C& |24 Plague vaccines 493
25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
26 Pneumococcal polysaccharide vaccines 542
0 c8 L; c# D# K2 d5 @* _* ^# X9 }27 Poliovirus vaccine-inactivated . 573
28 Poliovirus vaccine-live 598
6 G1 A2 [9 x9 z; u/ b29 Rabies vaccines .646
, E* D+ m" b6 `2 w/ c, ?30 Rotavirus vaccines . 669
31 Rubella vaccine 688
32 Smallpox and vaccinia 718
* ~' O" x2 H8 S3 F& @% v; G33 Tetanus toxoid 746
; H9 z# G5 Z! b( u34 Tick-borne encephalitis virus vaccines 773
35 Tuberculosis vaccines 789
36 Typhoid fever vaccines 812
37 Varicella vaccine 837
38 Yellow fever vaccine 870
39 Zoster vaccine 969
5 h2 H6 a: _6 \! u$ y2 H7 w40 Combination vaccines 981
SECTION 3: Vaccines in development and new vaccine strategies
% _: p4 k) w4 w# z7 i( u6 b. q41 Biodefense and special pathogen vaccines 1008
( u& r' b/ ^# l( f- R& ], Z/ T42 Therapeutic cancer vaccines 1018
43 Cytomegalovirus vaccines 1032
: _6 d( q" E' p+ p44 Dengue vaccines 1042
5 u$ Z8 W2 m" ?45 Diarrhea caused by bacteria 1052
5 G' j" P  m' F8 O! N: V- M) h46 Ebola vaccine 1060
47 Epstein-Barr virus vaccines 1068
48 Hepatitis C vaccines 1074
49 Hepatitis E vaccines 1085
% L& u% X- _( l! o50 Herpes simplex virus vaccines 1090
+ W; u+ S$ _" T# Z* \; v* C* R2 Y# D51 Human immunodeficiency virus vaccines 1097
1 Y+ _1 c8 K' J$ g/ X7 X52 Lyme disease vaccines 1122
53 Malaria vaccines 1133
54 Noninfectious disease vaccines 1138
, Y' _! ^& ~" k( \# R# u55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
56 Parasitic disease vaccines 1154
* ^7 c6 P! j9 p; g: ~* V8 ?57 Staphylococcus aureus vaccines 1161
58 Streptococcus group A vaccines 1169
. s& `- L3 I* l( F59 Streptococcus group B vaccines 1176
" I; R. C: e- U4 T60 Technologies for making new vaccines 1182
# f. s* }, P+ f3 J6 R61 Alternative vaccine delivery methods 1200
6 G8 p. Q2 }8 W% _. b" P* @* D# ?9 |62 The development of gene-based vectors for immunization 1232
, ~2 E) d7 l$ W- nSECTION 4: Vaccination of special groups
63 Vaccination of immunocompromised hosts 1243
# Z4 T: {9 V0 ^9 r( G4 q2 v* T/ k, L6 ^64 Vaccination of human immunodeficiency virus-infected persons 1257
65 Vaccines for international travel 1270
' U2 I5 Z1 y2 P8 n' f# @) g/ O, v66 Vaccines for health care personnel 1290
8 E% }2 T# j# `: nSECTION 5: Public health and regulatory issues
/ X+ c) a  @& L- ~4 O67 Immunization in the United States 1310
; f/ ^' Y! Y, X68 Immunization in Europe . 1334
69 Immunization in the Asia-Pacific region 1353
70 Immunization in developing countries 1369
" f$ Q; c4 g1 G8 I7 ^$ _71 Community immunity 1395
72 Economic analyses of vaccine policies 1413
73 Regulation and testing of vaccines 1427
! u' i# O' k) w( ?; ?74 Regulation of vaccines in Europe 1447
+ \2 g" t. z* B8 u" ?7 x3 @4 q75 Regulation of vaccines in developing countries 1454
76 Vaccine safety 1464
" v+ t* r+ K+ z: g* L77 Legal issues . 1481
# k" ?# x1 t0 v3 X% }78 Ethics 1508

7 K7 r0 X4 ~$ ~0 K4 H

salina

非常感谢

zhpu2008

谢谢分享

zhpu2008

怎么看不到相关下载呀

rojjer

( b1 M, s) M% n! T: s* t1 ?Vaccines, 6th Edition
8 A* d) e- Q# r3 m
/ |0 I; e/ j( c( ~Apply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.
  }( }( X  K' F, P: z
- ?# v0 i. m& L' x8 m& ^+ u: b, o1 zhttp://yun.baidu.com/share/link? ... 1&uk=3810996606
7 |! _: T6 n$ G( {
SECTION 1: General aspects of vaccination
1 A short history of vaccination 1
2 Vaccine immunology 14
3 The vaccine industry 33
4 Vaccine manufacturing 44
& S; F' ]/ o& ^6 S4 V( R$ P5 Evolution of adjuvants across the centuries 58
6 Vaccine additives and manufacturing residuals in the United States:
) B6 X8 p; Z2 V; U6 t# klicensed vaccines 71
7 Passive immunization 80
8 General immunization practices 88
6 {3 Q: S4 [  Y8 I7 O- Y. mSECTION 2: Licensed vaccines
9 Adenovirus vaccines 113
/ v1 V6 g# a2 W10 Anthrax vaccines 127
1 V& b5 A  ?% \& E9 P. e6 i3 d11 Cholera vaccines 141
* y4 U( F! L# J4 S12 Diphtheria toxoid 153
13 Haemophilus influenzae vaccines 167
3 B- X: e! b2 O( u/ P6 o14 Hepatitis A vaccines 183
15 Hepatitis B vaccines 205
9 ~, a7 w3 ^; H16 Human papillomavirus vaccines 235
! r5 z( M/ M0 |& {2 w+ g7 k5 O17 Inactivated influenza vaccines 257
18 Influenza vaccine-live 294
19 Japanese encephalitis vaccines 312
20 Measles vaccines 352
4 ~8 j  T8 H! u21 Meningococcal vaccines 388
: X7 K+ V' t3 |, o- t. y: n22 Mumps vaccine 419
0 n! Q0 }: y' @7 H4 i23 Pertussis vaccines . 447
% X" `. v  j) @$ p8 Y0 [+ U24 Plague vaccines 493
25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
4 X' |8 w9 W' R5 T1 q9 Y( i; L26 Pneumococcal polysaccharide vaccines 542
27 Poliovirus vaccine-inactivated . 573
9 U2 a0 r; z( u% i/ F' }% h28 Poliovirus vaccine-live 598
; G7 K2 a5 i. m2 C* L- s29 Rabies vaccines .646
- K9 }) I/ l5 ~30 Rotavirus vaccines . 669
31 Rubella vaccine 688
" F1 ?  ~( T% o. k9 G32 Smallpox and vaccinia 718
33 Tetanus toxoid 746
34 Tick-borne encephalitis virus vaccines 773
35 Tuberculosis vaccines 789
8 }( U& }9 y) Q! O36 Typhoid fever vaccines 812
0 O. }7 p/ J2 a9 L37 Varicella vaccine 837
38 Yellow fever vaccine 870
+ v: Z# v# a' t: o39 Zoster vaccine 969
  a3 g/ u' z9 V40 Combination vaccines 981
% |0 Z3 `  w  C5 H7 {SECTION 3: Vaccines in development and new vaccine strategies
41 Biodefense and special pathogen vaccines 1008
0 @' W1 N" U! r5 L' a7 W: @42 Therapeutic cancer vaccines 1018
) b- Z# f( B- F1 f43 Cytomegalovirus vaccines 1032
44 Dengue vaccines 1042
9 `5 m! q- N7 F. G+ S45 Diarrhea caused by bacteria 1052
6 z6 l6 b; b9 ^( h; g46 Ebola vaccine 1060
1 Q/ {+ O+ {! D* ^3 ]47 Epstein-Barr virus vaccines 1068
48 Hepatitis C vaccines 1074
49 Hepatitis E vaccines 1085
50 Herpes simplex virus vaccines 1090
51 Human immunodeficiency virus vaccines 1097
52 Lyme disease vaccines 1122
53 Malaria vaccines 1133
- {' V7 @! Q" T8 r8 p54 Noninfectious disease vaccines 1138
55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
56 Parasitic disease vaccines 1154
57 Staphylococcus aureus vaccines 1161
5 i# U  }9 R! p58 Streptococcus group A vaccines 1169
! }. E6 Q' a# l8 L+ P1 U  a59 Streptococcus group B vaccines 1176
% k. D& r; h  L. e60 Technologies for making new vaccines 1182
4 I9 ^4 L7 s+ h. e/ b5 V7 e! E61 Alternative vaccine delivery methods 1200
# s7 Z' `: |6 T% g$ r62 The development of gene-based vectors for immunization 1232
SECTION 4: Vaccination of special groups
  X; v4 ^  e  U63 Vaccination of immunocompromised hosts 1243
  z3 |5 M  t. @  {5 V$ b3 q64 Vaccination of human immunodeficiency virus-infected persons 1257
2 q( v+ |$ m) X: ~+ F65 Vaccines for international travel 1270
5 w. F$ F% [7 x/ X: C) e& }66 Vaccines for health care personnel 1290
SECTION 5: Public health and regulatory issues
6 _2 O1 w* a  C; Z67 Immunization in the United States 1310
68 Immunization in Europe . 1334
' w4 T6 ~% c, i3 a* z9 F- t0 q69 Immunization in the Asia-Pacific region 1353
70 Immunization in developing countries 1369
- C( N. y8 C- I' z71 Community immunity 1395
1 B! ~2 L/ N  O1 m" a72 Economic analyses of vaccine policies 1413
73 Regulation and testing of vaccines 1427
74 Regulation of vaccines in Europe 1447
0 i0 z: U- v( I% H75 Regulation of vaccines in developing countries 1454
6 G- p- C( I3 G: u( e4 Q76 Vaccine safety 1464
77 Legal issues . 1481
- u4 ^, G: l, u7 X% T+ g+ N: ]9 R$ l* w78 Ethics 1508

' I% I/ t/ o4 g
+ a4 X6 o* \" h5 [

casarett

Vaccines, 6e, 2012
- g. ^# ^; d) C6 |
8 m& x9 f$ k- Q/ y& q) y5 bHardcover: 1570 pages
2 ?) l1 E0 [& I$ KPublisher: Saunders; 6 edition (October 30, 2012)
1 j. O+ v3 c+ V1 r1 U5 J) b8 ELanguage: English
( `9 @6 S' k( k$ K3 U# P$ TISBN-10: 1455700908
: C* U/ o2 K; O9 b$ n" G$ A! vSize: 52.3mb (original pdf)
) u  e- ~/ S+ H. x
9 ]  `7 m* r  y. z" Y. X; F2013 BMA Medical Book Awards Highly Commended in Public Health!
8 ~: z) I0 u. h& Q: w( D. H/ `Apply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice!
5 X, \# c7 [9 J
Gain a complete understanding of each disease, including clinical characteristics, microbiology, pathogenesis, diagnosis, and treatment, as well as epidemiology and public health and regulatory issues.
- {. u/ g. d' [) `, _6 DUpdate your knowledge of both existing vaccines and vaccines currently in the research and development stage.
# ^' ?: z; B1 Z( X  oGet complete answers on each vaccine, including its stability, immunogenicity, efficacy, duration of immunity, adverse events, indications, contraindications, precautions, administration with other vaccines, and disease-control strategies.
Analyze the cost-benefit and cost-effectiveness of different vaccine options.
  `4 I- F& i: y5 e6 o: J' B) O; EClearly visualize concepts and objective data through an abundance of tables and figures.
3 R0 C; t2 x) GPerform seamless searches of the complete text online, access all the references, and download all the images at www.expertconsult.com.
2 ^% d0 C2 m3 m6 N' O; h, VMake optimal use of the latest vaccines for pneumococcal disease, rotavirus, human papillomavirus, herpes zoster, meningococcal disease, and much more.
7 i* l0 T9 ^; }2 s9 h3 m: z! I, \Stay at the forefront of new developments with completely updated chapters on malaria and HIV vaccines, a new chapter on vaccine regulations across the world, and many other revisions throughout.

Download link: http://pan.baidu.com/s/1i5NxwLR
Code for downloading: dv96
+ X5 R7 F' o4 h" e4 T